Skip to main content

Table 5 The predicting factors of the rate of SI change

From: Impact of preoperative docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy on degree of malignant esophageal stenosis

  

SI low group

(n = 39)

SI high group

(n = 42)

P value

Age

≥ 70 yrs. / 70 yrs.>

9 / 30

11 / 31

0.745 a

Sex

male / female

30 / 9

36 / 6

0.309 a

Tumor location

Ce / Ut / Mt / Lt / Ae

1 / 2 / 20 / 14 / 2

2 / 7 / 20 / 13 / 0

0.283 a

cStage (11th JES)

II / III / IVa

9 / 20 / 10

11 / 17 / 14

0.606 a

pStage (11th JES)

I / II / III / IVa

3 / 9 / 15 / 12

3 / 10 / 16 / 13

> 0.999 a

Overall response

SD + PD / PR + CR

29 / 10

27 / 15

0.327 a

Histopathological response

0 and 1 / 2 and 3

33 / 6

28 / 14

0.061 a

Regimen

FP / DCF

29 / 10

21 / 21

*0.024 a

  1. 11th JES, 11th edition of the Japanese Classification of Esophageal Cancer; Ce, cervical esophagus; Ut, upper thoracic esophagus; Mt, middle thoracic esophagus; Lt, lower thoracic esophagus; Ae, abdominal esophagus; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; FP, 5-fluorouracil and cisplatin; DCF, docetaxel, cisplatin, and 5-fluorouracil; SI, stenosis index (intraluminal stenotic area/length of stenosis);
  2. *P < 0.05
  3. a χ2 test
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us